Compass Pathways Plc ADR (CMPS) Stock Price, Quote & News

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities

Sector: Healthcare

Website: compasspathways.com

Address:

33 Broadwick Street, London, United Kingdom

McGuireTO Aug. 27 at 1:41 AM

$ATAI $CMPS $CYBN $MNMD - Click to watch the free analysis video. The Gilgamesh news confirmation saw a bullish sector-wide push into a little blow off top and a pretty steep selloff of double digit percentages. What can we expect from the sector over the rest of the week? We learned a lot today and tomorrow will be just as valuable, but here are the most likely scenarios I'm seeing based on how bulls shook off the hangover in today's trading session. I post regular technical analysis of the psychedelic sector and other. key charts. Be sure to like and follow to not miss an update! https://www.tradingview.com/chart/CMPS/1zeVS8aj-Psychedelic-Bears-Smack-down-what-happens-next/

0 · Reply

McGuireTO Aug. 26 at 8:40 PM

$ATAI $MNMD $CMPS $CYBN I learned a lot from today's price action after yesterday's gross profit taking candles and will be posting video analysis later this evening. Be sure to like and follow to not miss an important video at a key precipice in the charts for the psychedelic sector!

1 · Reply

DriuxP Aug. 26 at 8:36 PM

$ATAI $CMPS gotta admit, I did not see today being green after yesterday's reversal candles on these two. Cautiously optimistic about the rest of the week....

1 · Reply

Ramirami43 Aug. 26 at 4:10 PM

$CMPS last days

0 · Reply

PsychedStocks Aug. 26 at 2:15 PM

$CYBN $CMPS $ATAI $MNMD $SPY Cybin Receives Australian Approval for EMBRACE, a Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder https://ir.cybin.com/investors/news/news-details/2025/Cybin-Receives-Australian-Approval-for-EMBRACE-a-Multinational-Pivotal-Study-Evaluating-CYB003-for-the-Adjunctive-Treatment-of-Major-Depressive-Disorder/default.aspx

2 · Reply

DriuxP Aug. 26 at 6:03 AM

$ATAI $CMPS gnarly candles today, folks.

0 · Reply

Jbgs Aug. 26 at 5:37 AM

$ATAI $MNMD $CMPS https://stocktwits.com/news-articles/markets/equity/abbvie-to-acquire-gilgamesh-lead-candidate-for-up-to-1.2-billion/chssYI7Rd1u

0 · Reply

JonCollins Aug. 25 at 7:27 PM

$ATAI Psychedelic research could benefit in a massive way with marijuana reform hitting the news cycles. $MNMD $CYBN $CMPS

0 · Reply

McGuireTO Aug. 25 at 4:56 PM

$ATAI and $CMPS can still technically be hourly bull flags but $MNMD retracement to well below hourly EMA 12 has me looking for an hourly lower high next bounce. ATAI trying to turn $5 into support - good start. CMPS needs to turn $4.80 into support. Not there yet. MNMD trying to turn $10 into support - good start. But it really needs to turn $10.50 into support

0 · Reply

McGuireTO Aug. 25 at 4:35 PM

Red flags on the size of the pullback, especially for $MNMD but also $CMPS and $ATAI. Hourly higher lows remain in tact and will be our guides but this is NOT the response bulls want to see immediately after key weekly and monthly bull breaks

3 · Reply

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Jul 31, 2025, 10:32 AM EDT - 26 days ago

COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 6:30 AM EDT - 26 days ago

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 4 weeks ago

Compass Pathways Appoints Justin Gover to Board of Directors

Jul 22, 2025, 6:30 AM EDT - 5 weeks ago

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Jul 10, 2025, 4:00 PM EDT - 6 weeks ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jun 24, 2025, 2:47 PM EDT - 2 months ago

Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360

Jun 23, 2025, 8:25 AM EDT - 2 months ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Jun 23, 2025, 8:12 AM EDT - 2 months ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 6:48 AM EDT - 2 months ago

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:30 AM EDT - 2 months ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

May 14, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 8, 2025, 11:14 AM EDT - 3 months ago

COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript

May 8, 2025, 6:30 AM EDT - 3 months ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Apr 29, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 28, 2025, 6:30 AM EDT - 4 months ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 22, 2025, 6:00 AM EDT - 4 months ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 28, 2025, 5:01 PM EDT - 5 months ago

This Is a Test From GlobeNewswire

ALVO

Mar 26, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 11, 2025, 6:30 AM EDT - 6 months ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Feb 28, 2025, 5:08 PM EST - 6 months ago

Compass Pathways: Betting On The Future Of Psilocybin Therapy

Feb 27, 2025, 4:02 PM EST - 6 months ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 10:41 AM EST - 6 months ago

COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:30 AM EST - 6 months ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 25, 2025, 4:00 PM EST - 6 months ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 6:30 AM EST - 6 months ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 5, 2025, 6:30 AM EST - 7 months ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 21, 2025, 6:30 AM EST - 7 months ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 10, 2025, 7:01 AM EST - 8 months ago

Compass Pathways Announces Pricing of Underwritten Offering

Dec 18, 2024, 6:30 AM EST - 8 months ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Nov 25, 2024, 4:00 PM EST - 9 months ago

Compass Pathways to Participate in December Investor Conferences

Nov 14, 2024, 7:44 AM EST - 10 months ago

Compass Pathways to participate in Stifel 2024 Healthcare Conference

Nov 5, 2024, 6:58 AM EST - 10 months ago

Top 3 Health Care Stocks You'll Regret Missing In November

PACS SGHT

Nov 1, 2024, 5:10 PM EDT - 10 months ago

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Oct 31, 2024, 2:49 PM EDT - 10 months ago

COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 6:30 AM EDT - 10 months ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Oct 24, 2024, 6:30 AM EDT - 10 months ago

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Sep 23, 2024, 7:00 AM EDT - 1 year ago

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Aug 28, 2024, 6:00 AM EDT - 1 year ago

Compass Pathways to participate in three investor conferences in September

Aug 15, 2024, 12:30 PM EDT - 1 year ago

Psychedelic Stocks: Focus On Their Cash

MNMD

Aug 12, 2024, 12:12 PM EDT - 1 year ago

Psychedelic drug contender stocks drop after FDA rejects MDMA treatment

ATAI CYBN MNMD

Aug 4, 2024, 1:22 AM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways announces second quarter 2024 financial results and business highlights

Jul 24, 2024, 7:01 AM EDT - 1 year ago

Compass Pathways to announce second quarter financial results on August 1, 2024

Jul 8, 2024, 10:11 AM EDT - 1 year ago

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jun 26, 2024, 6:30 AM EDT - 1 year ago

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

Jun 24, 2024, 4:01 PM EDT - 1 year ago

Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

May 23, 2024, 12:15 PM EDT - 1 year ago

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

MNMD

May 11, 2024, 5:31 PM EDT - 1 year ago

COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript

McGuireTO Aug. 27 at 1:41 AM

0 · Reply

McGuireTO Aug. 26 at 8:40 PM

1 · Reply

DriuxP Aug. 26 at 8:36 PM

$ATAI $CMPS gotta admit, I did not see today being green after yesterday's reversal candles on these two. Cautiously optimistic about the rest of the week....

1 · Reply

Ramirami43 Aug. 26 at 4:10 PM

$CMPS last days

0 · Reply

PsychedStocks Aug. 26 at 2:15 PM

2 · Reply

DriuxP Aug. 26 at 6:03 AM

$ATAI $CMPS gnarly candles today, folks.

0 · Reply

Jbgs Aug. 26 at 5:37 AM

$ATAI $MNMD $CMPS https://stocktwits.com/news-articles/markets/equity/abbvie-to-acquire-gilgamesh-lead-candidate-for-up-to-1.2-billion/chssYI7Rd1u

0 · Reply

JonCollins Aug. 25 at 7:27 PM

$ATAI Psychedelic research could benefit in a massive way with marijuana reform hitting the news cycles. $MNMD $CYBN $CMPS

0 · Reply

McGuireTO Aug. 25 at 4:56 PM

0 · Reply

McGuireTO Aug. 25 at 4:35 PM

3 · Reply

BobJohnBuoy666 Aug. 25 at 3:37 PM

$ATAI beautiful chart, never followed this one that closely, if you positioned here, congrats! Every major ticker in this space is looking great! $CYBN $CMPS $MNMD

0 · Reply

McGuireTO Aug. 25 at 3:05 PM

$MNMD $CMPS $ATAI I was a day early but the charts told me everything I needed to know!

0 · Reply

Ramirami43 Aug. 25 at 3:02 PM

$CMPS

0 · Reply

jattboy Aug. 25 at 2:07 PM

$CMPS ATAI crossed 5 today !!

1 · Reply

BobJohnBuoy666 Aug. 25 at 1:52 PM

$CMPS price level support and holding above Friday's wedge breakout move. Very bullish.

0 · Reply

SlayQueenOfCalls Aug. 25 at 1:51 PM

$CMPS beautiful

0 · Reply

CCTVon Aug. 25 at 12:33 AM

$CMPS I see some bullish moves ahead with RFK Jr. and Trump pushing psychedelic treatments.

0 · Reply

WealthExchange Aug. 24 at 9:49 PM

$CMPS Got to have the psychedelic sector on major watch with RFK Jr in office. I like CMPS as a de-risked swing candidate for this upcoming macro theme play. They recently dropped on positive data on June 23rd but the market quickly saw the initial move as panic and are now trading back near the same price as before they reported achievement of primary endpoint. They don’t seem to have any data until H2 2026 & with a cash runway until 2027, I believe CMPS is one of the top candidates to hold a position on. I’d love a dip back to 3.50-4 for an entry to swing into 10-13 in 4-8 months. SL below 3

0 · Reply

Ramirami43 Aug. 24 at 7:28 PM

$CMPS ☝️ https://m.youtube.com/watch?v=x5yKvVpVig4&time_continue=105&source_ve_path=NzY3NTg&embeds_referring_euri=https%3A%2F%2Fwww.reddit.com%2F&embeds_referring_origin=https%3A%2F%2Fwww.reddit.com

0 · Reply

Ramirami43 Aug. 24 at 11:47 AM

$CMPS 🚀 https://www.marijuanamoment.net/gop-senator-is-confident-psychedelics-access-will-expand-under-trump-saying-many-veterans-speak-to-him-about-the-benefits/

0 · Reply

TheCatalystCalendar Aug. 24 at 11:45 AM

Even though Marijuana is struggling to get reclassified, RFK Jr is publicly very pro-psilocybin research. This reclassification, should it happen, would give doctors the ability to prescribe psilocybin for end of life care. And it just so happens there are at least 5 companies researching psilocybin that are worth exploring: $ATAI, $CMPS, $CYBN, $MNMD, $FTRP https://apple.news/AsJ1ClIurQmScoZMPaTydbA

3 · Reply

wgreg41 Aug. 24 at 4:58 AM

$CMPS https://finance.yahoo.com/news/compass-pathways-announces-second-quarter-103000317.html

0 · Reply

Market Cap	439.41M
Revenue (ttm)	0.00
Net Income (ttm)	-155.12M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.19

Volume	1,709,100
Avg Vol	3,223,456
Day's Range	N/A - N/A
Shares Out	95.94M
Stochastic %K	82%
Beta	2.17
Analysts	Strong Sell
Price Target	$14.90